Clinical Trial: Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Assessment of Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV

Brief Summary: This study has aim to describe the immune response to the second dose of Japanese encephalitis chimeric vaccine (JECV) in children previously vaccinated with one dose of JECV 5 years ago.

Detailed Summary: This is a prospective study to demonstrate the boosting antibody response in children previously vaccinated with one dose of JECV 5 years ago.
Sponsor: Khon Kaen University

Current Primary Outcome: Neutralizing antibody titers after JECV vaccination [ Time Frame: 28 days ]

Neutralizing antibody titers before JECV booster (on D0), and after IMOJEV booster (on D28)


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Khon Kaen University

Dates:
Date Received: September 26, 2013
Date Started: October 2013
Date Completion: May 2014
Last Updated: October 6, 2013
Last Verified: October 2013